论文部分内容阅读
目的:探讨止咳祛痰汤联合阿奇霉素对肺炎支原体肺炎患儿的临床疗效及安全性。方法:将90例肺炎支原体肺炎患儿随机分为对照组和观察组各45例,对照组患儿采用阿奇霉素治疗,观察组患儿采用止咳祛痰汤联合阿奇霉素治疗,比较两组患者的临床疗效、症状缓解情况、胸片恢复正常时间、不良反应情况。结果:观察组患儿咳嗽、发热、啰音等临床症状缓解情况优于对照组,胸片恢复正常时间为(9.1±2.6)天,不良反应发生率为6.67%,治疗总效率为95.6%,均明显优于对照组的(10.5±3.2)天、22.2%、86.7%,组间临床疗效比较差异具有统计学意义(P<0.05)。结论:止咳祛痰汤联合阿奇霉素治疗肺炎支原体肺炎患儿疗效显著,具有较高的安全性,值得临床推广应用。
Objective: To investigate the clinical efficacy and safety of cough-cured expectorant combined with azithromycin in children with Mycoplasma pneumoniae pneumonia. Methods: 90 cases of children with Mycoplasma pneumoniae pneumonia were randomly divided into control group and observation group of 45 cases, the control group of children treated with azithromycin, the observation group of children with cough cured sputum soup and azithromycin treatment, the clinical efficacy of two groups were compared , Symptom relief, chest X-ray recovery time, adverse reactions. Results: The relief of clinical symptoms in the observation group was better than that in the control group (9.1 ± 2.6 days), the adverse reaction rate was 6.67%, the total effective rate was 95.6% (10.5 ± 3.2) days, 22.2% and 86.7% in the control group, respectively. There were significant differences in the clinical efficacy between the two groups (P <0.05). Conclusion: Zhike Qutan Decoction combined azithromycin treatment of children with mycoplasma pneumoniae significant effect, with high safety, worthy of clinical application.